Trial · NCT05505734
Adverse events166
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 166
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Upper respiratory tract infection | Infections and infestations | BDA MDI (PT027) 160/180 μg | 65 | 1,209 | 74 |
| other | Upper respiratory tract infection | Infections and infestations | AS MDI (PT007) 180 µg | 73 | 1,212 | 80 |
| other | COVID-19 | Infections and infestations | BDA MDI (PT027) 160/180 μg | 62 | 1,209 | 63 |
| other | COVID-19 | Infections and infestations | AS MDI (PT007) 180 µg | 67 | 1,212 | 69 |
| other | Nasopharyngitis | Infections and infestations | BDA MDI (PT027) 160/180 μg | 45 | 1,209 | 46 |
| other | Nasopharyngitis | Infections and infestations | AS MDI (PT007) 180 µg | 32 | 1,212 | 34 |
| other | Sinusitis | Infections and infestations | BDA MDI (PT027) 160/180 μg | 38 | 1,209 | 41 |
| other | Sinusitis | Infections and infestations | AS MDI (PT007) 180 µg | 30 | 1,212 | 36 |
| other | Bronchitis | Infections and infestations | BDA MDI (PT027) 160/180 μg | 29 | 1,209 | 30 |
| other | Bronchitis | Infections and infestations | AS MDI (PT007) 180 µg | 32 | 1,212 | 36 |
| other | Cough | Respiratory, thoracic and mediastinal disorders | BDA MDI (PT027) 160/180 μg | 30 | 1,209 | 31 |
| other | Cough | Respiratory, thoracic and mediastinal disorders | AS MDI (PT007) 180 µg | 29 | 1,212 | 32 |
| serious | Appendicitis | Infections and infestations | BDA MDI (PT027) 160/180 μg | 2 | 1,209 | 2 |
| serious | Appendicitis | Infections and infestations | AS MDI (PT007) 180 µg | 1 | 1,212 | 1 |
| serious | Bacteraemia | Infections and infestations | BDA MDI (PT027) 160/180 μg | 0 | 1,209 | 0 |
| serious | Bacteraemia | Infections and infestations | AS MDI (PT007) 180 µg | 1 | 1,212 | 1 |
| serious | COVID-19 | Infections and infestations | BDA MDI (PT027) 160/180 μg | 1 | 1,209 | 1 |
| serious | COVID-19 | Infections and infestations | AS MDI (PT007) 180 µg | 0 | 1,212 | 0 |
| serious | COVID-19 pneumonia | Infections and infestations | BDA MDI (PT027) 160/180 μg | 1 | 1,209 | 1 |
| serious | COVID-19 pneumonia | Infections and infestations | AS MDI (PT007) 180 µg | 0 | 1,212 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05505734/events